文献速递临床微生物质量管理与危急值

WHO GFN 外部质量保证体系参与实验室对耐热弯曲杆菌鉴定与药敏试验能力(2003–2012)

Proficiency of WHO Global Foodborne Infections Network External Quality Assurance System Participants in Identification and Susceptibility Testing of Thermotolerant Campylobacter spp. from 2003 to 2012.
PubMed 文献 · J Clin Microbiol · 2018-10-25

该研究评估了世界卫生组织全球食源性感染网络外部质量保证体系参与实验室在9年间对耐热弯曲杆菌鉴定和药敏试验的表现。参与实验室主要为国家级实验室,正确鉴定率随年份波动于61.9%(2008年)至90.7%(2012年),药敏试验正确率在2009至2012年间从91.4%稳步升至93.6%。非洲实验室表现最差(正确鉴定60.0%,正确药敏86.8%),约10%的实验室报告了错误鉴定或药敏结果。

要点

  • 耐热弯曲杆菌鉴定正确率各年波动于61.9%至90.7%,药敏正确率2009–2012年从91.4%升至93.6%。
  • 非洲实验室表现最差,正确鉴定率60.0%,正确药敏率86.8%。
  • 约10%的实验室报告了错误鉴定或药敏结果,提示局部临床层面能力担忧。

核心结论

  • 参与WHO GFN EQAS的实验室对耐热弯曲杆菌的鉴定和药敏试验能力存在年度波动,非洲实验室表现最差,约10%的实验室出现错误结果,提示局部临床层面诊断能力令人担忧。

研究设计与样本

  • 研究分析了2003至2012年9年间参加WHO全球食源性感染网络外部质量保证体系的实验室对耐热弯曲杆菌鉴定和药敏试验的表现,参与者主要为国家级实验室,鼓励自我评估作为持续质量改进的一部分。

主要发现

  • 正确鉴定弯曲杆菌属的能力随年份变化,范围从61.9%(2008年)到90.7%(2012年)。
  • 对弯曲杆菌属正确进行抗菌药物敏感性试验的能力在2009至2012年测试期间从91.4%稳步上升至93.6%。
  • 非洲实验室表现最差,正确鉴定率为60.0%,正确药敏试验结果为86.8%。
  • 总体约10%的实验室报告了不正确的鉴定或药敏图。

临床怎么用

  • 由于大多数参与者为超国家参考实验室,这些数据提示需关注局部临床层面的诊断能力,应加强实验室培训和质量控制以改善患者管理和监测控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Campylobacter spp. are foodborne and waterborne pathogens. While rather accurate estimates for these pathogens are available in industrialized countries, a lack of diagnostic capacity in developing countries limits accurate assessments of prevalence in many regions. Proficiency in the identification and susceptibility testing of these organisms is critical for surveillance and control efforts. The aim of the study was to assess performance for identification and susceptibility testing of thermotolerant Campylobacter spp. among laboratories participating in the World Health Organization (WHO) Global Foodborne Infections Network (GFN) External Quality Assurance System (EQAS) over a 9-year period. Participants (primarily national-level laboratories) were encouraged to self-evaluate their performance as part of continuous quality improvement. The ability to correctly identify Campylobacter spp. varied by year and ranged from 61.9% (2008) to 90.7% (2012), and the ability to correctly perform antimicrobial susceptibility testing (AST) for Campylobacter spp. appeared to steadily increase from 91.4% to 93.6% in the test period (2009 to 2012). The poorest performance (60.0% correct identification and 86.8% correct AST results) was observed in African laboratories. Overall, approximately 10% of laboratories reported either an incorrect identification or antibiogram. As most participants were supranational reference laboratories, these data raise significant concerns regarding capacity and proficiency at the local clinical level. Addressing these diagnostic challenges is critical for both patient-level management and broader surveillance and control efforts.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Pedersen SK, Wagenaar JA, Vigre H, et al. Proficiency of WHO Global Foodborne Infections Network External Quality Assurance System Participants in Identification and Susceptibility Testing of Thermotolerant Campylobacter spp. from 2003 to 2012. J Clin Microbiol. 2018. PMID: 30209182. doi:10.1128/JCM.01066-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。